In NSCLC-associated brain metastases, Tregs contribute to an immunosuppressive tumor microenvironment, often appearing in increased numbers alongside elevated levels of myeloid-derived suppressor cells (MDSCs), monocytes PD-L1 and IL-6 in the peripheral blood of affected patients [30,31]. The gene discussed is IL6; the disease is neoplasm.